Menu
Response Biomedical offers a FDA cleared whole blood immunoassay NT-proBNP test, with our proprietary RAMP technology which detects the levels of N-terminal prohormone of brain natriuretic peptide in patients with congestive heart failure around the world. Read more about how this product will help your physicians and patients where a traditional BNP test cannot.
The Challenge
MANAGING PATIENTS WITH HEART FAILURE
- 1 out of 4 patients will be readmitted within 30 days of discharge, the highest rate of readmission of any discharge diagnosis
- 1 in 5 patients diagnosed with heart failure die within the first year and about half of people who develop heart failure die within 5 years of diagnosis
- Heart failure often presents with non-specific symptoms and is frequently confused with pneumonia or COPD
- Heart attacks and Coronary Heart Disease are two of the most expensive conditions to treat.
The Solution
TEST PRINCIPLES
RAMP NT-proBNP Test
- Provides rapid, accurate diagnoses and assessment of congestive heart failure.
- NT-proBNP is roughly 5 times more stable of a biomarker then BNP
- Better accuracy in mild heart failure patients because the levels of NT-proBNP are 2-10x higher
- Standardized to Roche Elecsys Lab Analyzer
Additional Information
24 Hour Technical Support Available for all RAMP Customers
Contact Our Specialists
Start Testing Today
